Study of AL58805 for advanced gynecologic, soft tissue, or breast cancers
Treatments studied
Part of Cancer, Skin, Women’s health & pregnancy clinical trials.
This study tests an experimental drug called AL58805 for people with advanced cancers of the uterus, cervix, soft tissue, or breast that have not responded to standard treatments. The drug is taken as a pill and may work by blocking pathways that help tumors grow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have advanced or recurrent cancer of the uterus, cervix, soft tissue, or breast that has progressed after at least one standard treatment.
- You must not have any standard treatment options left.
- You must be able to swallow pills and have adequate organ function (blood cells, heart, liver, kidneys).
- You must be willing to use birth control if you can become pregnant.
- You must not have certain heart conditions, uncontrolled high blood pressure, or other serious medical issues that could be risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental pill for several advanced cancers, including soft tissue sarcoma, endometrial cancer, low-grade ovarian cancer, and glioblastoma. The goal is to see how safe the drug is and if it can slow down or shrink tumors.
This trial tests a new study medicine called PF-08634404 when combined with standard chemotherapy for people with advanced or recurrent endometrial cancer that is MMR-proficient (meaning the DNA repair system is working normally). The goal is to see if adding this medicine helps shrink or control the cancer better than chemotherapy alone.
This trial is testing a new drug called AL58805 for people with advanced cancers that have not improved with standard treatments. The goal is to see if the drug is safe and can help shrink tumors.
This study tests a new medicine, PF-08032562, for people with advanced breast or colorectal cancer that has not responded to prior treatments. It aims to see if the drug is safe and can help shrink or slow the cancer.
This trial tests a new combination of drugs (HRS-6208 with HRS-8080, fulvestrant, or letrozole) for people with advanced or metastatic breast cancer that cannot be removed by surgery. It aims to see if these combinations can help shrink or slow the cancer.
This trial tests a new oral drug called AL8326 for people with advanced small cell lung cancer who have already tried at least two other treatments. The goal is to see if the drug can shrink tumors and help patients live longer.
Hear when a new Endometrial Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.